IMMEDIATE RESULTS OF LAPAROSCOPIC SLEEVE RESECTION OF THE GASTRICITY IN COMORBID COURSE OF OBESITY AND TYPE 2 DIABETES MELLITUS

Authors

Sh.T. Samieva1 2  D.A. Rakhmonov²  Sh.Sh. Amonov² B.H. Khakimzoda² F.B. Bokiev2 Kh.T. Yuldasheva2
Job:

Medical Center of the Executive Office of the President of the Republic of Tajikistan

Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Tajikistan
DOI:
10.65197/3106-4035-2026-2-1-46-63

Annotation

Resume.

Goal.

To evaluate the impact of laparoscopic sleeve gastrectomy on body weight, glucose metabolism, and remission rates of type 2 diabetes in patients with morbid obesity.

Material and methods.

A prospective observation was conducted on 59 patients with obesity and type 2 diabetes. Twentysix patients underwent laparoscopic sleeve gastrectomy (study group), while 33 patients received conservative therapy including lifestyle modification and medication (control group). Assessments included body mass index (BMI), fasting glucose, glycated hemoglobin (HbA1c), HOMAIR, and lipid profile before surgery and at 12 months followup. These data demonstrate a comprehensive improvement in the metabolic status of patients after laparoscopic sleeve gastrectomy compared with conservative therapy: significant weight loss, normalization of carbohydrate metabolism, improvement of the lipid profile, and a high rate of remission of type 2 diabetes. The results of the study confirm the high efficacy of laparoscopic sleeve gastrectomy in achieving weight loss and improving carbohydrate metabolism in patients with morbid obesity and type 2 diabetes. A significant decrease in body mass index (from 46.3 to 29.8 kg/m²) over 12 months after surgery demonstrates a significant advantage of surgical intervention over conservative therapy, where the reduction in BMI was moderate (from 44.2 to 39.9 kg/m²).

Results.

Patients in the study group demonstrated significant reductions in BMI (46.3 → 29.8 kg/m²), normalization of fasting glucose and HbA1c (11.0 → 6.1 mmol/L and 9.3% → 5.9%, respectively), improvement in HOMAIR (7.9 → 3.3), and favorable changes in lipid profile. The control group showed only moderate improvements without achieving full diabetes remission.

Conclusion.

Thus, laparoscopic sleeve gastrectomy is an effective method for weight loss and correction of metabolic disorders in patients with morbid obesity and type 2 diabetes, surpassing the results of conservative treatment.

Keywords

obesity morbid obesity type 2 diabetes bariatric surgery metabolic syn-drome body mass index (BMI).

Full text

The article is in PDF format

List of literature

  1. 1. Lee W.J., Almulaifi A., Tsou J.J., Ser K.H., Lee Y.C., Chen S.C. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score. Surg Obes Relat Dis. 2015;11(5):991-996. doi: 10.1016/j.soard.2014.12.027.
  2. 2. Yip S., Plank L.D., Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta analysis of outcomes. Obes Surg. 2013;23(12):1994-2003.
  3. 3. Liu S.Y., Wong S.K., Lam C.C., Yung M.Y., Kong A.P., Ng E.K. Long-term results on weight loss and diabetes remission after laparoscopic sleeve gastrectomy for a morbidly obese Chinese population. Obes Surg. 2015;25(10):1901-1908. doi: 10.1007/s11695-015-1628-4.
  4. 4. Wang L., Wang J., Jiang T. Effect of laparoscopic sleeve gastrectomy on type 2 diabetes mellitus in patients with body mass index less than 30 kg/m². Obes Surg. 2019;29(3):835-842. doi: 10.1007/s11695-018-3602-4.
  5. 5. Abbatini F., Rizzello M., Casella G., Alessandri G., Capoccia D., Leonetti F., Basso N. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24(5):1005-1010. doi: 10.1007/s00464-009-0715-9.
  6. 6. Gill R.S., Birch D.W., Shi X., Sharma A.M., Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6(6):707-713. doi: 10.1016/j.soard.2010.07.011.
  7. 7. Guraya S.Y., Strate T. Surgical outcome of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass for resolution of type 2 diabetes mellitus: A systematic review and meta-analysis. World J Gastroenterol. 2020;26(8):865-876. doi: 10.3748/wjg.v26.i8.865.
  8. 8. Vitiello A., Abu-Abeid A., Dayan D., Berardi G., Musella M. Long-term results of laparoscopic sleeve gastrectomy: a review of studies reporting 10+ years outcomes. Obes Surg. 2023;33(11):3565-3570. doi: 10.1007/s11695-023-06824-8.
  9. 9. Mizera M., Wysocki M., Bartosiak K., Franczak P., Hady H.R., Kalinowski P., Myśliwiec P., Orłowski M., Paluszkiewicz R., Piecuch J., Szeliga J., Walędziak M., Major P., Pędziwiatr M. Type 2 diabetes remission 5 years after laparoscopic sleeve gastrectomy: multicenter cohort study. Obes Surg. 2021;31(3):980-986. doi: 10.1007/s11695-020-05088-w.
  10. 10. Hoogerboord M., Wiebe S., Klassen D., Ransom T., Lawlor D., Ellsmere J. Laparoscopic sleeve gastrectomy: perioperative outcomes, weight loss and impact on type 2 diabetes mellitus over 2 years. Can J Surg. 2014;57(2):101-105. doi: 10.1503/cjs.024212.
  11. 11. Cho J.M., Kim H.J., Lo Menzo E., Park S., Szomstein S., Rosenthal R.J. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systematic review and meta-analysis. Surg Obes Relat Dis. 2015;11(6):1273-1280. doi: 10.1016/j.soard.2015.03.001.
  12. 12. Wallenius V., Dirinck E., Fändriks L., Maleckas A., le Roux C.W., Thorell A. Glycemic control after sleeve gastrectomy and Roux-en-Y gastric bypass in obese subjects with type 2 diabetes mellitus. Obes Surg. 2018;28(6):1461-1472. doi: 10.1007/s11695-017-3061-3.
  13. 13. Li J.F., Lai D.D., Lin Z.H., Jiang T.Y., Zhang A.M., Dai J.F. Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutan Tech. 2014;24(1):1-11. doi: 10.1097/SLE.0000000000000041.
  14. 14. Nannipieri M., Baldi S., Mari A., Colligiani D., Guarino D., Camastra S., Barsotti E., Berta R., Moriconi D., Bellini R., Anselmino M., Ferrannini E. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab. 2013;98(11):4391-4399. doi: 10.1210/jc.2013-2538.
  15. 15. Peterli R., Steinert R.E., Woelnerhanssen B., Peters T., Christoffel-Courtin C., Gass M., Kern B., von Fluee M., Beglinger C. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740-748. doi: 10.1007/s11695-012-0622-3.
  16. 16. Todkar J.S., Shah S.S., Shah P.S., Gangwani J. Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):142-145. doi: 10.1016/j.soard.2009.06.008.
  17. 17. Samat A., Malin S.K., Huang H., Schauer P.R., Kirwan J.P., Kashyap S.R. Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab. 2013;15(10):963-966. doi: 10.1111/dom.12118.
  18. 18. Pekkarinen T., Mustonen H., Sane T., Jaser N., Juuti A., Leivonen M. Long-term effect of gastric bypass and sleeve gastrectomy on severe obesity: do preoperative weight loss and binge eating behavior predict the outcome of bariatric surgery? Obes Surg. 2016;26(9):2161-2167. doi: 10.1007/s11695-016-2090-7.
  19. 19. Khodjamuradov G.M., Shaimanov A.Kh., Saidov M.S., Shamsov N.Kh., Mirzoev N.M. Gastric surgery and other types of surgical interventions for obesity: comparative evaluation of results. Eurasian Scientific Medical Journal "Sino". 2024;5(1):47-54.
  20. 20. Khakimzoda B.Kh., Rakhmonov D.A. Experience of performing minimally invasive interventions for obesity in the Republic of Tajikistan. Plastic Surgery and Reconstructive Medicine. 2025;1(1):6-15. doi: 10.65197/3106-4035-2025-1-1-6-15.
Information
Language

English

License

CC BY 4.0

Category

MINIMALLYINVASIVE SURGERY

FINANCING

There was no financial support.

CONFLICT OF INTEREST

The authors declare no conflict of inter-est.

INFORMATION ABOUT THE AUTHORS:

*Samieva Shakhnoza Timurovna – candidate of medical sciences, endocrinologist at the Medical Center of the Executive Office of the President of the Republic of Tajikistan, Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Tajikistan.

E-mail: shaha4ka-92@mail.ru

https://orcid.org/0000-0003-1426-9855

 

Rakhmonov Dzhamakhon Ahmadovich – Candidate of Medical Sciences, Director of the Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Tajikistan.

E-mail: jama-7878@mail.ru

https://orcid.org/0000-0002-4427-0155

 

Amonov Shukhrat Shodievich – Doctor of Medical Sciences, Leading Researcher of the Department of Endoscopic Surgery of the Republican Scientific Center for Cardiovascular Surgery, Associate Professor of the Department of Surgical Diseases No. 2 named after Academician

N. U. Usmanov, State Educational Institution “Tajik State Medical University named after Avicenna”, Dushanbe, Tajikistan.

https://orcid.org/0000-0002-3702-6584

E-mail: shuhrat.amonov@yandex.ru

 

Hakimzoda Behruzjoni Hamid – Head of the Department of Bariatrics and Herniology, Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Ta-jikistan. E-mail: b.hakimzoda@yandex.ru

https://orcid.org/0000-0003-4096-5782

 

Bokiev Fathullo Bakhshulloevich – can-didate of medical sciences, physician of the bariatrics and herniology department of the Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Tajikistan https://orcid.org/0000-0003-2807-2324 E-mail: fathullo-@mail.ru

 

Yuldasheva Kholida Tursunkulovna – physician of the bariatrics and herniology department of the Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Tajikistan https://orcid.org/0009-0000-2532-005X 

E-mail: yuldasheva01@yahoo.com

*Correspondence address.